Corient Private Wealth
JAZZ icon

Corient Private Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

Corient Private Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Buy
13,071
+2,810
+27% +$616K ﹤0.01% 1094
2026
Q1 		$1.91M Buy
10,261
+61
+0.6% +$10.7K ﹤0.01% 1298
2025
Q4 		$1.73M Buy
10,200
+4,863
+91% +$746K ﹤0.01% 1226
2025
Q3 		$703K Sell
5,337
-1,100
-17% -$132K ﹤0.01% 1610
2025
Q2 		$669K Sell
6,437
-7,189
-53% -$781K ﹤0.01% 1550
2025
Q1 		$1.69M Buy
13,626
+2,769
+26% +$361K ﹤0.01% 1034
2024
Q4 		$1.34M Buy
10,857
+2,784
+34% +$328K ﹤0.01% 1181
2024
Q3 		$899K Buy
8,073
+307
+4% +$33.6K ﹤0.01% 1447
2024
Q2 		$829K Sell
7,766
-2,938
-27% -$323K ﹤0.01% 1401
2024
Q1 		$1.29M Sell
10,704
-508
-5% -$62.2K ﹤0.01% 1226
2023
Q4 		$1.38M Sell
11,212
-219
-2% -$27.3K ﹤0.01% 1163
2023
Q3 		$1.48M Buy
11,431
+145
+1% +$19.3K ﹤0.01% 1040
2023
Q2 		$1.4M Sell
11,286
-6,403
-36% -$861K ﹤0.01% 1034
2023
Q1 		$2.59M Sell
17,689
-770
-4% -$114K 0.01% 764
2022
Q4 		$2.94M Buy
+18,459
New +$2.71M 0.01% 611

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Corient Private Wealth's JAZZ Position: Q2 2026 in Review

Corient Private Wealth increased its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q2 2026, buying an estimated $616K and bringing the position to 13,071 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

Corient Private Wealth first reported a position in JAZZ in Q4 2022 and has held it in 15 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Corient Private Wealth held 13,071 shares of Jazz Pharmaceuticals worth $3.15M as of Q2 2026.
  • Corient Private Wealth bought 2,810 Jazz Pharmaceuticals shares in Q2 2026, an estimated $616K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1094 holding.
  • Corient Private Wealth first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.